MENU
GMAB
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Genmab A/S ADS (GMAB) Earnings Date & Reports

A.I. Advisor
published Earnings

GMAB is expected to report earnings to fall 82.94% to 14 cents per share on May 08

Genmab A/S ADS GMAB Stock Earnings Reports
Q1'25
Est.
$0.14
Q4'24
Beat
by $0.49
Q3'24
Missed
by $0.02
Q2'24
Beat
by $0.01
Q1'24
Est.
$0.29
The last earnings report on February 12 showed earnings per share of 84 cents, beating the estimate of 35 cents. With 1.06M shares outstanding, the current market capitalization sits at 14.09B.
View a ticker or compare two or three
GMAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

an international biotechnology company, which develops human antibody therapeutics for the treatment of cancer and other diseases.

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
Carl Jacobsens Vej 30
Phone
+45 70202728
Employees
2204
Web
https://www.genmab.com